Veikko Salomaa

Author PubWeight™ 27.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 2014 5.78
2 Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2014 2.10
3 Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase. J Am Coll Cardiol 2016 1.49
4 The genetic architecture of type 2 diabetes. Nature 2016 1.43
5 Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease. PLoS Genet 2016 1.39
6 Association of Cardiometabolic Multimorbidity With Mortality. JAMA 2015 1.32
7 The impact of low-frequency and rare variants on lipid levels. Nat Genet 2015 1.20
8 Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 2016 1.08
9 Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet 2015 1.08
10 Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet 2016 1.02
11 Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J 2016 0.87
12 A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism. PLoS Genet 2015 0.86
13 Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium. PLoS One 2016 0.82
14 Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence. Int J Epidemiol 2016 0.81
15 metaCCA: summary statistics-based multivariate meta-analysis of genome-wide association studies using canonical correlation analysis. Bioinformatics 2016 0.81
16 NT-proBNP and the risk of dementia: a prospective cohort study with 14 years of follow-up. J Alzheimers Dis 2015 0.80
17 Prognosis of acute coronary events is worse in patients living alone: the FINAMI myocardial infarction register. Eur J Prev Cardiol 2013 0.80
18 Metabolic profiling of alcohol consumption in 9778 young adults. Int J Epidemiol 2016 0.78
19 Serum tissue-degrading proteinases and incident cardiovascular disease events. Eur J Prev Cardiol 2012 0.77
20 Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium. Eur Heart J 2017 0.76
21 Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med 2016 0.76
22 Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. J Am Heart Assoc 2017 0.76
23 Characterization of the metabolic profile associated with serum 25-hydroxyvitamin D: a cross-sectional analysis in population-based data. Int J Epidemiol 2016 0.75
24 The Contribution of GWAS Loci in Familial Dyslipidemias. PLoS Genet 2016 0.75
25 Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome. PLoS One 2017 0.75
26 Prediction of sudden cardiac death with automated high-throughput analysis of heterogeneity in standard resting 12-lead electrocardiograms. Heart Rhythm 2015 0.75
27 Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome. Atherosclerosis 2017 0.75
28 High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study. J Neurol 2016 0.75
29 Genome-wide association meta-analysis of fish and EPA+DHA consumption in 17 US and European cohorts. PLoS One 2017 0.75
30 Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nat Genet 2017 0.75
31 Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer. Int J Cancer 2017 0.75
32 Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation 2017 0.75